VoxCell BioInnovation

VoxCell BioInnovation is a biotechnology company focused on creating vascularized, human-like cancer tissue models through 3D bioprinting technology. The company combines a custom high-resolution 3D bioprinter, advanced software, and proprietary bio-inks to produce these models. VoxCell's primary goal is to accelerate the development of life-saving anti-cancer drugs by providing tissue models that can identify viable drug candidates earlier in the development pipeline. The company's technology allows for the creation of tissue models containing capillary-sized vasculature, along with the chemical composition and mechanical strength of specific soft tissues, both healthy and cancerous.

VoxCell's universal bioink kit, described as multi-component mixtures, provides mechanical characteristics and biocompatibility favorable to cell growth and proliferation. This kit can mimic 12 different soft tissue types and is compatible with various bioprinting systems. The company's bio-printed human-like cancer tissue models allow drug developers to directly inject their drug candidates through blood vessels, enabling the identification of ineffective drugs much earlier in the process. While currently focused on cancer tissues, VoxCell is also exploring applications for neurodegenerative diseases such as Alzheimer's and Parkinson's.